Investor news Investor newsFinancial reportsInvest in InifyCompany overviewCorporate governanceExecutive teamBoard of directorsSustainabilityThe shareFinancial calendarContactsSubscription All202320222021Annual General MeetingPrimary Insider Transactions2023-05-17Inify Laboratories AB (publ) – summary of Annual General Meeting2023-04-26Inify Laboratories - Strong market interest and launch on track2023-04-12Inify Laboratories - Annual Report 20222023-04-12Inify Laboratories - notice of Annual General Meeting on May 16, 20232023-02-23Panel talk about Inify’s fourth quarter 20222023-02-22Inify Laboratories - Ultramodern AI-based digital pathology laboratory completed in record time2022-11-09Panel talk about Inify’s third quarter2022-10-26Inify Laboratories - Laboratory and recruitment on track with positive market feedback2022-08-30Inify Laboratories AB (publ) – Extraordinary General Meeting2022-08-19Inify Laboratories – mandatory notification of trade2022-08-17Inify’s first ultramodern laboratory on track2022-07-28Notice to Extraordinary General Meeting in Inify Laboratories AB (publ)2022-07-28Notice to Extraordinary General Meeting in Inify Laboratories AB (publ)2022-06-29Inify Laboratories announces the appointment of Chief Medical Officer (CMO)2022-06-20Inify Laboratories – now listed on Euronext Growth in Oslo under the INIFY ticker2022-06-16Inify Laboratories – Decision on admission to trading – Euronext Growth Oslo2022-05-30Inify Laboratories – Extended subscription period2022-05-09Inify Laboratories – extra bolagsstämma 2022-05-092022-04-11Inify Laboratories – kallelse till extra bolagsstämma2021-12-10Inify Laboratories AB becomes an independent company2021-11-15ContextVision to focus pathology efforts on the establishment of a fully AI-supported lab service2021-10-21Aiming to build the company’s first modern pathology lab